Biomarkers in Pain and Pain Treatment
The Effect of Inflammation on Psychological Comorbidity and Behavioral Treatment in Chronic Pain
1 other identifier
observational
90
0 countries
N/A
Brief Summary
The goal of this research project is to explore if levels of inflammation predict levels of comorbid mood disorders and treatment success in chronic pain patients. More knowledge in this respect will advance our understanding of chronic pain and comorbid syndromes, and facilitate subgroupings of patients based on the presence and/or level of low-grade inflammation. This research is an important step towards finding an explanation to why treatment effects following behavioral interventions differ across individuals, and generate new hypothesis regarding novel treatment approaches. The specific aims are: 1) to explore if baseline levels of inflammatory biomarkers predict the effects of behavioral intervention and 2) to investigate if baseline levels of inflammatory biomarkers are associated with psychological co-morbidity (e.g. depression, anxiety and fatigue) in patients with chronic pain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 6, 2016
CompletedFirst Submitted
Initial submission to the registry
August 15, 2017
CompletedFirst Posted
Study publicly available on registry
September 6, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 12, 2018
CompletedFebruary 26, 2020
February 1, 2020
2 years
August 15, 2017
February 24, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Treatment success
The Pain Disability Index
At last psychological session (3 months post baseline)
Secondary Outcomes (2)
Comorbid psychological problems
At first psychological session (baseline)
Blood biomarkers as an effect of treatment
At last psychological session (3 months post baseline)
Other Outcomes (1)
Blood biomarkers as predictor for treatment success
At first psychological session (baseline)
Interventions
The main component in the treatment is exposure to symptoms and feared situations. The iACT program is adapted from the evidence based face-to-face treatment at the Behavioral Medicine unit at Karolinska University Hospital. The iACT program has a different structure but is equal in content to face-to-face treatment, and is to be completed within ten weeks. Participants receive texts, audio files, movies and exercises and have online contact with their psychologist via an internet platform or a smart phone application. The treatment aims to encourage valued behaviors in the presence of inner discomfort.
Eligibility Criteria
The patients at the Karolinska Pain Center, suffering from chronic pain that does not respond to any other pain treatments and affects daily functioning severely.
You may qualify if:
- Referred to a specialist clinic within pain management
- Equal to or older than 18 years
- Chronic pain (\> 6 months)
- The pain is refractory
- The pain results in significant functional limitations
- Stable medication in the last 2 months and no planned changes in medication (except possibly discontinuation or lowering of current dose)
You may not qualify if:
- Spontaneous improvement can be expected (without treatment)
- Psychiatric comorbidity a) is deemed to be the main reason for the restrictions, or b) should be promptly evaluated and possibly treated, or c) may adversely affect the treatment given in the context of the study
- Significant risk of suicide
- Poor teamwork, defined as repeated missed appointments during the assessment / investigation phase
- Language difficulties (Swedish)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Rikard Wickselllead
- AFA Insurancecollaborator
- The Swedish Society of Medicinecollaborator
Related Publications (1)
Lasselin J, Kemani MK, Kanstrup M, Olsson GL, Axelsson J, Andreasson A, Lekander M, Wicksell RK. Low-grade inflammation may moderate the effect of behavioral treatment for chronic pain in adults. J Behav Med. 2016 Oct;39(5):916-24. doi: 10.1007/s10865-016-9769-z. Epub 2016 Jul 28.
PMID: 27469518BACKGROUND
Biospecimen
plasma, whole blood
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rikard Wicksell, PhD
Karolinska Institutet
- STUDY CHAIR
Bianka Karshikoff, PhD
Karolinska Institutet
- STUDY CHAIR
Linda Holmström, PhD
Karolinska Institutet
- STUDY CHAIR
Mats Lekander, PhD
Karolinska Institutet
- STUDY CHAIR
Jenny Åström, lic psych
Karolinska University Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Director of Functional Area Medical Psychology, Karolinska Univ Hospital and head of research group Behavior Medicine, KI
Study Record Dates
First Submitted
August 15, 2017
First Posted
September 6, 2017
Study Start
December 6, 2016
Primary Completion
December 12, 2018
Last Updated
February 26, 2020
Record last verified: 2020-02
Data Sharing
- IPD Sharing
- Will not share